Stock listing
NASDAQ:MGRX Mangoceuticals, Inc. Stock
Home listing (NASDAQ) of Mangoceuticals, Inc.
Follow Mangoceuticals, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:MGRX
$0.124 USD -0.023 (-15.6%)
Close on Nov 20, 2026
- Day range
- $0.121 – $0.137 USDNov 20, 2026
- Volume
- 241,103 sharesNov 20, 2026
- Market cap
- $2.75M USDAt the close on Nov 20, 2026 · price × 22.22M shares outstanding
- 52-week range
- $0.121 – $1.380 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $210,701 USDMedian day 431,700 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:MGRX · Home | $0.124 USD | -0.023 (-15.6%) | 241,103 | $0.133 | $0.137 | $0.121 | $0.147 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:MGRX · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.124 | -0.023 | -15.6% | $0.133 | $0.137 | $0.121 | 241,103 | |
| $0.147 | -0.014 | -8.4% | $0.162 | $0.162 | $0.144 | 465,180 | |
| $0.160 | 0.000 | -0.2% | $0.169 | $0.169 | $0.156 | 395,945 | |
| $0.160 | +0.005 | +3.4% | $0.157 | $0.170 | $0.153 | 423,536 | |
| $0.155 | -0.030 | -16.2% | $0.172 | $0.188 | $0.150 | 962,065 | |
| $0.185 | -0.014 | -7.2% | $0.190 | $0.204 | $0.177 | 8,706,112 | |
| $0.199 | +0.010 | +5.3% | $0.188 | $0.203 | $0.188 | 256,581 | |
| $0.189 | -0.008 | -4.0% | $0.199 | $0.214 | $0.183 | 261,916 | |
| $0.197 | +0.002 | +1.1% | $0.202 | $0.210 | $0.195 | 116,020 | |
| $0.195 | +0.003 | +1.6% | $0.192 | $0.209 | $0.186 | 320,023 | |
| $0.192 | -0.015 | -7.4% | $0.206 | $0.228 | $0.185 | 463,877 | |
| $0.207 | -0.011 | -5.0% | $0.212 | $0.219 | $0.203 | 149,579 | |
| $0.218 | -0.010 | -4.4% | $0.243 | $0.243 | $0.196 | 852,437 | |
| $0.228 | -0.005 | -2.3% | $0.238 | $0.242 | $0.225 | 438,345 | |
| $0.233 | -0.021 | -8.2% | $0.257 | $0.260 | $0.229 | 521,676 | |
| $0.254 | -0.004 | -1.5% | $0.269 | $0.270 | $0.243 | 233,512 | |
| $0.258 | +0.010 | +4.1% | $0.251 | $0.265 | $0.248 | 380,753 | |
| $0.248 | +0.004 | +1.6% | $0.250 | $0.260 | $0.218 | 130,240 | |
| $0.244 | +0.012 | +5.3% | $0.226 | $0.254 | $0.222 | 317,296 | |
| $0.232 | -0.012 | -4.9% | $0.249 | $0.258 | $0.231 | 290,700 | |
| $0.244 | -0.051 | -17.3% | $0.296 | $0.305 | $0.236 | 926,700 | |
| $0.295 | -0.005 | -1.7% | $0.291 | $0.305 | $0.291 | 76,000 | |
| $0.300 | +0.020 | +7.1% | $0.290 | $0.305 | $0.280 | 176,800 | |
| $0.280 | -0.010 | -3.4% | $0.290 | $0.309 | $0.280 | 752,700 | |
| $0.290 | -0.031 | -9.7% | $0.336 | $0.345 | $0.285 | 262,700 | |
| $0.321 | -0.007 | -2.1% | $0.340 | $0.362 | $0.320 | 663,700 | |
| $0.328 | -0.044 | -11.8% | $0.375 | $0.380 | $0.307 | 676,300 | |
| $0.372 | -0.011 | -2.9% | $0.380 | $0.394 | $0.370 | 299,200 | |
| $0.383 | -0.039 | -9.2% | $0.420 | $0.420 | $0.381 | 449,300 | |
| $0.422 | -0.010 | -2.3% | $0.435 | $0.440 | $0.410 | 431,700 | |
| $0.432 | -0.012 | -2.7% | $0.435 | $0.460 | $0.423 | 583,800 | |
| $0.444 | -0.006 | -1.3% | $0.433 | $0.478 | $0.430 | 646,100 | |
| $0.450 | +0.032 | +7.7% | $0.423 | $0.456 | $0.411 | 831,700 | |
| $0.418 | -0.019 | -4.3% | $0.427 | $0.438 | $0.409 | 576,700 | |
| $0.437 | -0.044 | -9.1% | $0.426 | $0.444 | $0.426 | 876,200 | |
| $0.481 | +0.053 | +12.4% | $0.430 | $0.520 | $0.425 | 2,132,400 | |
| $0.428 | -0.017 | -3.8% | $0.431 | $0.445 | $0.428 | 204,300 | |
| $0.445 | +0.060 | +15.6% | $0.386 | $0.459 | $0.380 | 1,139,000 | |
| $0.385 | -0.081 | -17.4% | $0.450 | $0.457 | $0.370 | 1,001,800 | |
| $0.466 | +0.002 | +0.4% | $0.452 | $0.479 | $0.452 | 83,200 | |
| $0.464 | +0.015 | +3.3% | $0.439 | $0.480 | $0.435 | 557,600 | |
| $0.449 | +0.018 | +4.2% | $0.425 | $0.460 | $0.413 | 407,700 | |
| $0.431 | -0.020 | -4.4% | $0.450 | $0.457 | $0.410 | 472,700 | |
| $0.451 | -0.025 | -5.3% | $0.465 | $0.480 | $0.444 | 435,600 | |
| $0.476 | +0.031 | +7.0% | $0.450 | $0.480 | $0.395 | 1,590,200 | |
| $0.445 | -0.007 | -1.5% | $0.445 | $0.460 | $0.437 | 304,300 | |
| $0.452 | +0.032 | +7.6% | $0.430 | $0.472 | $0.430 | 1,079,400 | |
| $0.420 | +0.010 | +2.4% | $0.410 | $0.440 | $0.405 | 406,900 | |
| $0.410 | +0.007 | +1.7% | $0.392 | $0.420 | $0.385 | 578,300 | |
| $0.403 | +0.018 | +4.7% | $0.380 | $0.408 | $0.376 | 287,800 | |
| $0.385 | -0.031 | -7.5% | $0.404 | $0.414 | $0.380 | 150,000 | |
| $0.416 | +0.005 | +1.2% | $0.420 | $0.420 | $0.404 | 192,800 | |
| $0.411 | 0.000 | 0.0% | $0.403 | $0.420 | $0.392 | 278,600 | |
| $0.411 | +0.021 | +5.4% | $0.386 | $0.422 | $0.375 | 519,700 | |
| $0.390 | +0.006 | +1.6% | $0.377 | $0.399 | $0.376 | 200,800 | |
| $0.384 | -0.007 | -1.8% | $0.378 | $0.398 | $0.373 | 188,100 | |
| $0.391 | +0.001 | +0.3% | $0.390 | $0.395 | $0.373 | 212,900 | |
| $0.390 | -0.012 | -3.0% | $0.402 | $0.402 | $0.380 | 252,300 | |
| $0.402 | +0.002 | +0.5% | $0.391 | $0.424 | $0.390 | 430,400 | |
| $0.400 | +0.027 | +7.2% | $0.369 | $0.426 | $0.369 | 758,000 | |
| $0.373 | -0.015 | -3.8% | $0.388 | $0.388 | $0.363 | 275,600 | |
| $0.388 | +0.005 | +1.2% | $0.360 | $0.409 | $0.360 | 559,427 | |
| $0.383 | -0.039 | -9.2% | $0.369 | $0.385 | $0.360 | 955,686 | |
| $0.422 | +0.036 | +9.3% | $0.380 | $0.430 | $0.365 | 1,145,800 | |
| $0.386 | -0.032 | -7.7% | $0.406 | $0.408 | $0.383 | 1,030,300 |
Splits
1 split · NASDAQ:MGRX · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-15 | Consolidation |
- Ticker
- NASDAQ:MGRX
- Asset type
- Stock
- Sector
- Health care
- Industry
- Health care services
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Nov 12, 2026
Mangoceuticals Partners with T7X to Become the First Nasdaq-Listed Company to Offer Tokenized Preferred Stock on the T7X Platform
Latest news
Mangoceuticals Partners with T7X to Become the First Nasdaq-Listed Company to Offer Tokenized Preferred Stock on the T7X Platform
Nov 12, 2026
Closed $0.185 (-7.2%) on Nov 12, 2026
Mangoceuticals Closes Registered Direct Offering Priced at 74% Premium to Recent Market Close
Oct 9, 2026
Closed $0.383 (-9.2%) on Oct 12, 2026
Mangoceuticals Secures $2.5 Million Strategic Investment in MangoRx IP Holdings; Receives Initial $1.75 Million Tranche
Oct 1, 2026
Closed $0.481 (+12.4%) on Oct 1, 2026
Mangoceuticals Inc.’s Merger Partner, Nuclea Energy, Inc., Enters into Definitive Agreement to Acquire Moltex Energy’s Advanced Nuclear Technology Assets
Aug 13, 2026
Closed $0.534 (+0.2%) on Aug 14, 2026
Mangoceuticals’ Merger Partner, Nuclea Energy (“Nuclea”), Executes MOU with Utah Office of Energy Development
Aug 5, 2026
Closed $0.527 (+23.7%) on Aug 6, 2026
Mangoceuticals Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement and Comments on Nuclea Energy Business Combination
Aug 4, 2026
Closed $0.426 (-7.0%) on Aug 5, 2026
Mangoceuticals Announces Business Combination Agreement with Nuclea Energy Inc. to Advance Next-Generation Nuclear Microreactor Technology
Jul 30, 2026
Closed $0.294 (-46.8%) on Jul 30, 2026
Mangoceuticals Announces Lawsuit Seeking Damages Exceeding $73 Million Against Former Technology Consulting and Software Development Firm, Clarity Ventures, Inc.
Mar 17, 2026
Closed $0.40 (-1.0%) on Mar 17, 2026
Mangoceuticals, Inc. on 6ix
- Sector
- Health care
- Industry
- Health care services
- News releases
- 14 in the last 12 months · 95 in all · newest Nov 12, 2026 · oldest 2023
Where Mangoceuticals, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:MGRX · Home listing · This page | NASDAQ | United States | USD |
| BOATS:MGRX | BOATS | United States | USD |
Valuation
EV/sales 9.1× against a median of 0.6×: the highest of 8 Health care services companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- $2.73M USD
- P/E
- Loss
- EV/sales
- 9.1×
- EV/EBITDA
- Negative EBITDA
- Price/book
- 0.3×
- Gross margin
- 52.9%
- Operating margin
- Revenue too small
- Net margin
- Revenue too small
- Debt to equity
- 0.1×
- Beta vs S&P 500
- 0.60
Health care services: the 10 companies nearest in size, of 419 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Mangoceuticals, Inc. · NASDAQ:MGRX | US$2.75M | US$2.73M | n/a | 9.1× | n/a | 0.3× | n/a | 0.1× | 0.60 |
| Regional Health Properties, Inc. · OTC:RHEP | US$3.30M | US$43.79M | 17.6× | 0.5× | 8.7× | n/a | 0.2% | n/a | 0.34 |
| Seegnal Inc. · TSXV:SEGN | US$3.26M | US$4.27M | n/a | 3.1× | n/a | n/a | −468.5% | n/a | 0.26 |
| PanGenomic Health, Inc. Class A · CSE:NARA | US$3.23M | US$3.22M | n/a | n/a | n/a | n/a | n/a | n/a | -0.34 |
| Basel Medical Group Ltd · NASDAQ:BMGL | US$2.91M | US$9.95M | n/a | 0.6× | 1.1× | 0.7× | −3.5% | 1.9× | 0.58 |
| Polomar Health Services, Inc. · OTC:PMHS | US$2.84M | US$2.58M | n/a | n/a | n/a | n/a | n/a | n/a | 0.25 |
| UniDoc Health Corp. · CSE:UDOC | US$2.71M | US$2.66M | n/a | 4.0× | n/a | n/a | −327.1% | n/a | -0.61 |
| Modern Mobility Aids, Inc. · OTC:MDRM | US$2.68M | US$2.71M | n/a | n/a | n/a | n/a | n/a | n/a | -0.74 |
| Healthcare Triangle, Inc. · NASDAQ:HCTI | US$2.63M | US$17.54M | n/a | 0.6× | n/a | 0.1× | −56.4% | 0.3× | 2.08 |
| Monsenso A/S · OMXCOP:MONSO | US$2.57M | US$2.69M | n/a | 2.1× | n/a | 2.6× | −81.0% | 0.1× | n/a |
| Visionflex Group Limited · ASX:VFX | US$2.30M | US$1.61M | n/a | 0.6× | n/a | n/a | −1.4% | n/a | n/a |
| Median of the others | US$2.77M | US$2.97M | 17.6× | 0.6× | 4.9× | 0.7× | −56.4% | 0.3× | 0.26 |
Team and board
Officers
| Officer | Role |
|---|---|
| Jacob Cohen | Chairman, Co-Founder and Chief Executive Officer |
| Eugene M. Johnston | Chief Financial Officer |
| Amanda Hammer | Chief Operating Officer |
Board
| Director | Role |
|---|---|
| Jacob Cohen | Chairman, Co-Founder and Chief Executive Officer |
| Alex P. Hamilton | Independent Director |
| Kenny Myers | Independent Director |
| Lorraine D’Alessio | Independent Director |
Events
| Quarter | Results | Share move |
|---|---|---|
| Q3 2026 | Nov 16, 2026 | +3.2% |
| Q2 2026 | Aug 13, 2026 | +0.2% |
| Q3 2025 | Nov 14, 2025 | +5.9% |
| Q2 2025 | Aug 14, 2025 | −3.5% |
| Q1 2025 | May 15, 2025 | −6.1% |
| Q4 2024 | Mar 20, 2025 | +4.5% |
| Q1 2023 | May 10, 2023 | +3.5% |
| Q4 2022 | Feb 6, 2023 | |
| Q2 2022 | Sep 26, 2022 |
Financings
| Raise | Date |
|---|---|
| Series D Cumulative Convertible Preferred Stock (tokenized) Announced: up to US$10M · US$10 a share Use of proceeds: General corporate purposes and working capital | Nov 12, 2026 |
| Registered direct offering of units of one share of common stock and one warrant Closed: US$500,000 raised · US$0.75 a unit · one warrant Use of proceeds: Additional working capital | Oct 9, 2026 |
| Strategic investment of membership interests in MangoRx IP Holdings, LLC Tranche closed: US$1.75M raised Use of proceeds: To advance commercialization of the antiviral intellectual property portfolio held by MangoRx IP | Oct 1, 2026 |
| Registered direct offering of common Units (or Pre-Funded Units) of common stock and PIPE common warrants Closed: US$2.5M raised · US$1.295 a unit · Warrants at US$1.4245 · Aegis Capital Corp. Dealers: Aegis Capital Corp. (lead) Use of proceeds: General corporate purposes and working capital | Dec 19, 2025 |
Open Financings · Read by 6ix AI from the company's releases
IPO
Priced at US$4.00 a share on Mar 20, 2023.
- Price
- US$4.00 a share
- Shares offered
- 1,250,000 shares of common stock
- Offering size
- US$5 million
- Listing
- MGRX on the Nasdaq Capital Market
- Underwriters
- Boustead Securities, LLC, Sutter Securities, Inc. · In the order on the cover
- Shares delivered
- On or about Mar 23, 2023
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Sep 26, 2022 |
| Filed publicly | Jan 13, 2023 |
| Amended 4 times | Newest Feb 28, 2023 |
| Shares registered with an exchange | Feb 6, 2023 |
| Declared effective by the SEC | Mar 20, 2023 |
| Final prospectus, with the price | Mar 22, 2023 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Mar 22, 2023 |
| 424B4 · Prospectus | Mar 22, 2023 |
| CERT · Exchange's certificate of listing | Mar 21, 2023 |
| EFFECT · Notice that a registration is effective | Mar 20, 2023 |
| CORRESP · Letter to the SEC | Mar 17, 2023 |
| CORRESP · Letter to the SEC | Mar 17, 2023 |
| CORRESP · Letter to the SEC | Mar 17, 2023 |
| CORRESP · Letter to the SEC | Mar 17, 2023 |
| CORRESP · Letter to the SEC | Mar 14, 2023 |
| CORRESP · Letter to the SEC | Mar 14, 2023 |
All 32 filings
Open IPO · From the cover of the final prospectus (424B4) filed Mar 22, 2023
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 456.0K | 615.9K | 731.5K | 8.94K | |
| Cost of revenue | 54.4K | 93.3K | 154.9K | 4.09K | |
| Gross profit | 250.4K | 380.0K | 431.5K | 4.85K | |
| Selling, general and administrative | 15.9M | 6.42M | 3.32M | 1.64M | 70.1K |
| Operating income | -18.0M | -7.97M | -9.22M | -1.99M | -17.5K |
| Depreciation and amortization | 1.01K | 9.94K | 24.9K | 3.86K | 3.86K |
| EBITDA | -18.0M | -7.96M | -9.19M | -1.99M | -13.7K |
| Interest expense | 103.5K | 13.7K | -6.47K | 6.47K | 181 |
| Income before tax | -20.6M | -8.71M | -9.21M | -2.00M | -17.7K |
| Income tax | 1 | -224.6K | -70.1K | ||
| Net income | -20.6M | -8.71M | -9.21M | -2.00M | -17.7K |
| Earnings per share, basic | -2.17 | -4.80 | -8.58 | -0.19 | -0.02 |
| Earnings per share, diluted | -2.17 | -4.80 | -8.58 | -0.19 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Cash and equivalents | 1.49M | 58.7K | 739.0K | 682.9K | 22.6K |
| Receivables | 0 | ||||
| Inventory | 0 | 18.5K | 0 | ||
| Current assets | 1.55M | 75.6K | 835.4K | 694.6K | 22.6K |
| Property, plant and equipment | 1.79K | 2.81K | 96.1K | 117.5K | |
| Total assets | 16.1M | 15.4M | 1.05M | 1.00M | 22.6K |
| Accounts payable | 416.7K | 837.5K | 140.8K | 33.7K | |
| Current liabilities | 890.6K | 1.43M | 211.1K | 260.6K | 39.3K |
| Total debt | 307.8K | 215.0K | 128.7K | 352.9K | 39.3K |
| Total liabilities | 890.6K | 1.43M | 276.0K | 389.3K | 39.3K |
| Shareholders' equity | 15.2M | 13.9M | 774.8K | 614.0K | -16.7K |
| Shares outstanding | 15.9M | 3.25M | 1.43M | 13.4M | 1.15M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Cash from operations | -5.85M | -4.86M | -7.00M | -1.35M | -17.5K |
| Capital spending | -5 | 0 | -3.52K | -43.1K | -43.1K |
| Free cash flow | -5.85M | -4.86M | -7.00M | -1.39M | -17.5K |
| Cash from investing | 65.0K | -3.52K | -43.1K | -43.1K | |
| Cash from financing | 7.27M | 4.13M | 7.06M | 2.05M | 40.1K |
| Dividends paid | -802.1K | ||||
| Change in cash | 1.42M | -670.5K | 56.1K | 660.3K | 22.6K |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| ARS · Annual report to shareholders | Nov 19, 2026 | Annual report | SEC |
| DEF 14A · Proxy statement | Nov 17, 2026 | Meeting notice | SEC |
| 10-Q · Quarterly report | Nov 16, 2026 | Quarterly report | SEC |
| 8-K · Current report | Nov 13, 2026 | Meeting outcome | SEC |
| 1-A | Nov 12, 2026 | Other filings | SEC |
| 8-K · Current report | Nov 6, 2026 | Meeting outcome | SEC |
| PRE 14A · Preliminary proxy statement | Nov 6, 2026 | Meeting notice | SEC |
| 8-K · Current report | Oct 9, 2026 | Material contract | SEC |
| 424B5 · Prospectus | Oct 9, 2026 | Offer document | SEC |
| 4 · Change in ownership | Oct 6, 2026 | Insider trade | SEC |
Show 200 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 4 · Change in ownership | Oct 6, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Oct 6, 2026 | Insider trade | SEC |
| SCHEDULE 13D/A · Big-stake notice, amended | Oct 6, 2026 | Big-stake notice | SEC |
| 8-K · Current report | Oct 1, 2026 | Acquisition or disposal | SEC |
| 8-K · Current report | Aug 21, 2026 | Current report | SEC |
| 10-Q · Quarterly report | Aug 13, 2026 | Quarterly report | SEC |
| 425 | Aug 13, 2026 | Other filings | SEC |
| 425 | Aug 5, 2026 | Other filings | SEC |
| 425 | Aug 4, 2026 | Other filings | SEC |
| 8-K · Current report | Aug 4, 2026 | Current report | SEC |
| 425 | Jul 30, 2026 | Other filings | SEC |
| 425 | Jul 30, 2026 | Other filings | SEC |
| 8-K · Current report | Jul 30, 2026 | Material contract | SEC |
| S-8 · Registration statement for employee plans | Jul 10, 2026 | Offer document | SEC |
| 8-K · Current report | Jul 2, 2026 | Material contract | SEC |
| 10-Q · Quarterly report | May 19, 2026 | Quarterly report | SEC |
| NT 10-Q · Late filing notice | May 15, 2026 | Explanation request | SEC |
| 10-K · Annual report | Apr 1, 2026 | Annual report | SEC |
| NT 10-K · Late filing notice | Mar 31, 2026 | Explanation request | SEC |
| 4 · Change in ownership | Mar 20, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 20, 2026 | Insider trade | SEC |
| 8-K · Current report | Mar 17, 2026 | Management or board change | SEC |
| 8-K · Current report | Feb 23, 2026 | Current report | SEC |
| 8-K · Current report | Feb 19, 2026 | Current report | SEC |
| 8-K · Current report | Feb 6, 2026 | Current report | SEC |
| EFFECT · Notice that a registration is effective | Jan 29, 2026 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Jan 27, 2026 | Other filings | SEC |
| CORRESP · Letter to the SEC | Jan 26, 2026 | Other filings | SEC |
| S-1/A · Registration statement, amended | Jan 23, 2026 | Offer document | SEC |
| S-1 · Registration statement | Jan 13, 2026 | Offer document | SEC |
| 8-K · Current report | Dec 19, 2025 | Material contract | SEC |
| 424B5 · Prospectus | Dec 19, 2025 | Offer document | SEC |
| 8-K · Current report | Dec 19, 2025 | Material contract | SEC |
| 4 · Change in ownership | Dec 17, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 11, 2025 | Insider trade | SEC |
| 8-K · Current report | Dec 10, 2025 | Material contract | SEC |
| 4 · Change in ownership | Dec 9, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Dec 3, 2025 | Other filings | SEC |
| 4 · Change in ownership | Nov 26, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Nov 19, 2025 | Other filings | SEC |
| 10-Q · Quarterly report | Nov 14, 2025 | Quarterly report | SEC |
| 10-Q/A · Quarterly report, amended | Nov 14, 2025 | Quarterly report | SEC |
| 8-K · Current report | Nov 14, 2025 | Current report | SEC |
| 8-K · Current report | Nov 13, 2025 | Current report | SEC |
| 8-K · Current report | Oct 28, 2025 | Material contract | SEC |
| 4 · Change in ownership | Sep 30, 2025 | Insider trade | SEC |
| SCHEDULE 13D/A · Big-stake notice, amended | Sep 30, 2025 | Big-stake notice | SEC |
| 4 · Change in ownership | Sep 12, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Sep 12, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Sep 12, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Sep 12, 2025 | Insider trade | SEC |
| 8-K · Current report | Sep 12, 2025 | Management or board change | SEC |
| 8-K · Current report | Sep 2, 2025 | Material contract | SEC |
| 10-Q · Quarterly report | Aug 14, 2025 | Quarterly report | SEC |
| 8-K · Current report | Aug 4, 2025 | Acquisition or disposal | SEC |
| 8-K · Current report | Jul 22, 2025 | Material contract | SEC |
| 8-K · Current report | Jul 9, 2025 | Current report | SEC |
| 8-K · Current report | Jul 3, 2025 | Management or board change | SEC |
| EFFECT · Notice that a registration is effective | Jun 25, 2025 | Other filings | SEC |
| CORRESP · Letter to the SEC | Jun 20, 2025 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Jun 20, 2025 | Other filings | SEC |
| EFFECT · Notice that a registration is effective | Jun 20, 2025 | Other filings | SEC |
| CORRESP · Letter to the SEC | Jun 17, 2025 | Other filings | SEC |
| S-3 · Registration statement | Jun 13, 2025 | Offer document | SEC |
| 8-K · Current report | Jun 10, 2025 | Financing | SEC |
| UPLOAD · Letter from the SEC | Jun 6, 2025 | Other filings | SEC |
| S-1 · Registration statement | May 30, 2025 | Offer document | SEC |
| 8-K · Current report | May 29, 2025 | Material contract | SEC |
| 8-K · Current report | May 23, 2025 | Acquisition or disposal | SEC |
| 10-Q · Quarterly report | May 15, 2025 | Quarterly report | SEC |
| 8-K · Current report | May 6, 2025 | Material contract | SEC |
| 8-K · Current report | Apr 25, 2025 | Acquisition or disposal | SEC |
| 8-K · Current report | Apr 17, 2025 | Material contract | SEC |
| 8-K · Current report | Apr 11, 2025 | Management or board change | SEC |
| 4 · Change in ownership | Apr 11, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Apr 11, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Apr 11, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Apr 11, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Apr 11, 2025 | Insider trade | SEC |
| SCHEDULE 13D/A · Big-stake notice, amended | Apr 11, 2025 | Big-stake notice | SEC |
| 8-K · Current report | Apr 8, 2025 | Financing | SEC |
| 8-K · Current report | Apr 2, 2025 | Financing | SEC |
| S-8 · Registration statement for employee plans | Apr 1, 2025 | Offer document | SEC |
| 8-K · Current report | Mar 28, 2025 | Financing | SEC |
| 8-K · Current report | Mar 25, 2025 | Material contract | SEC |
| 10-K · Annual report | Mar 20, 2025 | Annual report | SEC |
| 8-K · Current report | Mar 19, 2025 | Management or board change | SEC |
| 8-K · Current report | Feb 19, 2025 | Material contract | SEC |
| DEF 14A · Proxy statement | Feb 18, 2025 | Meeting notice | SEC |
| 8-K · Current report | Feb 12, 2025 | Material contract | SEC |
| 8-K · Current report | Feb 12, 2025 | Current report | SEC |
| 424B3 · Prospectus | Feb 10, 2025 | Offer document | SEC |
| 424B3 · Prospectus | Feb 10, 2025 | Offer document | SEC |
| 8-K · Current report | Feb 7, 2025 | Management or board change | SEC |
| PRE 14A · Preliminary proxy statement | Feb 6, 2025 | Meeting notice | SEC |
| 8-K · Current report | Jan 31, 2025 | Material contract | SEC |
| SCHEDULE 13G · Big-stake notice | Jan 22, 2025 | Big-stake notice | SEC |
| 8-K · Current report | Jan 21, 2025 | Material contract | SEC |
| 3 · Initial statement of ownership | Jan 21, 2025 | Insider trade | SEC |
| 8-K · Current report | Jan 15, 2025 | Current report | SEC |
| 8-K · Current report | Jan 8, 2025 | Material contract | SEC |
| 8-K · Current report | Dec 26, 2024 | Material contract | SEC |
| 8-K · Current report | Dec 19, 2024 | Acquisition or disposal | SEC |
| 8-K · Current report | Dec 6, 2024 | Material contract | SEC |
| 10-Q · Quarterly report | Nov 14, 2024 | Quarterly report | SEC |
| 4 · Change in ownership | Nov 12, 2024 | Insider trade | SEC |
| 8-K · Current report | Nov 12, 2024 | Management or board change | SEC |
| 8-K · Current report | Oct 31, 2024 | Current report | SEC |
| 8-K · Current report | Oct 25, 2024 | Financing | SEC |
| 8-K · Current report | Oct 22, 2024 | Material contract | SEC |
| 8-K · Current report | Oct 21, 2024 | Current report | SEC |
| 8-K · Current report | Oct 11, 2024 | Current report | SEC |
| 8-K · Current report | Oct 3, 2024 | Current report | SEC |
| 8-K · Current report | Oct 2, 2024 | Financing | SEC |
| 8-K · Current report | Oct 1, 2024 | Current report | SEC |
| 8-K · Current report | Sep 27, 2024 | Financing | SEC |
| EFFECT · Notice that a registration is effective | Sep 6, 2024 | Other filings | SEC |
| CORRESP · Letter to the SEC | Sep 3, 2024 | Other filings | SEC |
| AW | Aug 30, 2024 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Aug 29, 2024 | Other filings | SEC |
| SC 13D/A · Big-stake notice, amended | Aug 27, 2024 | Big-stake notice | SEC |
| 4 · Change in ownership | Aug 27, 2024 | Insider trade | SEC |
| 8-K · Current report | Aug 23, 2024 | Management or board change | SEC |
| S-1 · Registration statement | Aug 16, 2024 | Offer document | SEC |
| 8-K · Current report | Aug 15, 2024 | Results | SEC |
| 10-Q · Quarterly report | Aug 14, 2024 | Quarterly report | SEC |
| POS AM · Amendment to an effective registration | Jul 26, 2024 | Offer document | SEC |
| 8-K · Current report | Jul 11, 2024 | Material contract | SEC |
| 8-K · Current report | Jul 2, 2024 | Material contract | SEC |
| 4 · Change in ownership | Jun 27, 2024 | Insider trade | SEC |
| 144/A · Notice of proposed sale, amended | Jun 24, 2024 | Other filings | SEC |
| 144/A · Notice of proposed sale, amended | Jun 20, 2024 | Other filings | SEC |
| 144 · Notice of proposed sale | Jun 18, 2024 | Other filings | SEC |
| 8-K · Current report | Jun 17, 2024 | Meeting outcome | SEC |
| 144 · Notice of proposed sale | Jun 10, 2024 | Other filings | SEC |
| 8-K · Current report | Jun 5, 2024 | Management or board change | SEC |
| 4 · Change in ownership | Jun 5, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jun 5, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jun 5, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jun 5, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jun 5, 2024 | Insider trade | SEC |
| SC 13D/A · Big-stake notice, amended | Jun 5, 2024 | Big-stake notice | SEC |
| ARS · Annual report to shareholders | May 16, 2024 | Annual report | SEC |
| DEF 14A · Proxy statement | May 16, 2024 | Meeting notice | SEC |
| 10-Q · Quarterly report | May 15, 2024 | Quarterly report | SEC |
| S-8 · Registration statement for employee plans | May 14, 2024 | Offer document | SEC |
| EFFECT · Notice that a registration is effective | May 10, 2024 | Other filings | SEC |
| CORRESP · Letter to the SEC | May 7, 2024 | Other filings | SEC |
| S-1/A · Registration statement, amended | May 6, 2024 | Offer document | SEC |
| PRE 14A · Preliminary proxy statement | May 6, 2024 | Meeting notice | SEC |
| 8-K · Current report | May 2, 2024 | Current report | SEC |
| UPLOAD · Letter from the SEC | Apr 30, 2024 | Other filings | SEC |
| 8-K · Current report | Apr 25, 2024 | Acquisition or disposal | SEC |
| S-1 · Registration statement | Apr 23, 2024 | Offer document | SEC |
| 8-K · Current report | Apr 11, 2024 | Material contract | SEC |
| 10-K · Annual report | Apr 1, 2024 | Annual report | SEC |
| 8-K · Current report | Mar 26, 2024 | Management or board change | SEC |
| DEF 14A · Proxy statement | Mar 1, 2024 | Meeting notice | SEC |
| PRE 14A · Preliminary proxy statement | Feb 20, 2024 | Meeting notice | SEC |
| 8-K · Current report | Jan 25, 2024 | Current report | SEC |
| 8-K · Current report | Jan 22, 2024 | Current report | SEC |
| 4 · Change in ownership | Dec 29, 2023 | Insider trade | SEC |
| SC 13D/A · Big-stake notice, amended | Dec 29, 2023 | Big-stake notice | SEC |
| 8-K · Current report | Dec 29, 2023 | Management or board change | SEC |
| EFFECT · Notice that a registration is effective | Dec 20, 2023 | Other filings | SEC |
| 8-K · Current report | Dec 19, 2023 | Material contract | SEC |
| POS AM · Amendment to an effective registration | Dec 18, 2023 | Offer document | SEC |
| POS AM · Amendment to an effective registration | Dec 15, 2023 | Offer document | SEC |
| EFFECT · Notice that a registration is effective | Dec 15, 2023 | Other filings | SEC |
| S-1/A · Registration statement, amended | Dec 12, 2023 | Offer document | SEC |
| CORRESP · Letter to the SEC | Dec 11, 2023 | Other filings | SEC |
| CORRESP · Letter to the SEC | Dec 11, 2023 | Other filings | SEC |
| CORRESP · Letter to the SEC | Dec 11, 2023 | Other filings | SEC |
| S-1 · Registration statement | Dec 11, 2023 | Offer document | SEC |
| CORRESP · Letter to the SEC | Dec 11, 2023 | Other filings | SEC |
| 8-K · Current report | Dec 11, 2023 | Material contract | SEC |
| UPLOAD · Letter from the SEC | Nov 30, 2023 | Other filings | SEC |
| DRS · Draft registration statement | Nov 24, 2023 | Offer document | SEC |
| 8-K · Current report | Nov 7, 2023 | Current report | SEC |
| 8-K · Current report | Nov 1, 2023 | Current report | SEC |
| 10-Q · Quarterly report | Oct 27, 2023 | Quarterly report | SEC |
| 8-K · Current report | Oct 19, 2023 | Results | SEC |
| 4 · Change in ownership | Oct 4, 2023 | Insider trade | SEC |
| 8-K · Current report | Oct 4, 2023 | Management or board change | SEC |
| 8-K · Current report | Sep 21, 2023 | Material contract | SEC |
| 8-K · Current report | Sep 8, 2023 | Material contract | SEC |
| 10-Q · Quarterly report | Jul 28, 2023 | Quarterly report | SEC |
| 8-K · Current report | Jun 23, 2023 | Financing | SEC |
| 10-Q · Quarterly report | May 9, 2023 | Quarterly report | SEC |
| 4 · Change in ownership | May 4, 2023 | Insider trade | SEC |
This page holds 200 of 247 filings. Open Filings
Cap table
Built by 6ix from Mangoceuticals, Inc.’s releases · as of Nov 12, 2026
- Common shares
- 22,224,422
- Fully diluted
- 22,891,089
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 22,224,422 | Oct 9, 2026 |
| Warrants | 666,667 | Oct 9, 2026 |
Warrants and options
| Lot |
|---|
| Warrants · expiry not stated |
| Warrants · US$1.42 · expiry not stated |
Share count over time
| Count | Shares |
|---|---|
| Oct 9, 2026 | 22,224,422 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Antonios Isaac Other companies: AI Financial Corporation (Chief Executive Officer, Director · May 18, 2015 – Jan 5, 2023 · Past); Live Ventures Incorporated (Director · Dec 12, 2011 – Jun 30, 2023 · Past) | President, Director · Jan 14, 2025 – Apr 10, 2025 · Past |
| Alex P Hamilton Other companies: Addentax Group Corp. (Director · Since at least May 24, 2024) | Director · Since at least Mar 20, 2023 |
| Alex P. Hamilton(汉密尔顿) Other companies: Addentax Group Corp. (独立董事 · Since at least Nov 4, 2026) | Independent Director · Since at least Oct 6, 2026 |
| Jacob Cohen Other companies: American International Holdings Corp. (Director · Apr 12, 2019 – May 6, 2022 · Past) | Chairman, Co-Founder and Chief Executive Officer · Since at least Mar 20, 2023 |
| Kenny Myers Other companies: American International Holdings Corp. (Director · Jan 13, 2022 – Jan 13, 2022 · Past) | Director · Since at least Mar 20, 2023 |
| Lorraine D’Alessio Other companies: American International Holdings Corp. (Director · Jan 13, 2022 – Jan 13, 2022 · Past) | Independent Director · Since at least Mar 20, 2023 |
| Amanda Hammer | Chief Operating Officer · Since at least Jun 3, 2024 |
| Eugene M. Johnston | Chief Financial Officer · Since at least Mar 20, 2023 |
| Kenny Myers | Independent Director · Since at least Nov 4, 2026 |
Log in to ask 6ix AI your own questions about Mangoceuticals, Inc.